Schedule 13D ownership disclosure

SOLENO THERAPEUTICS INC

Security class unavailable · CUSIP: 834203200

Event date: 2018-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-18-000999
Form type
SC 13D
Filer
Abingworth LLP
CIK
CIK 1397144
Filed
Dec 27, 2018
Reporting period
Dec 21, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub